Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Anand Ganesan
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 289 Results
Response Adapted Neoadjuvant Therapy in Gastric Cancer (RANT-GC) Trial
Farshid Dayyani
- OPEN TO ACCRUAL
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents with Sickle Cell Disease
Zahra Pakbaz
- OPEN TO ACCRUAL
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Jay Shah
- OPEN TO ACCRUAL
RepurposingRiluzoleAugmentBrainDerivedNeuropathFactorLevel&CogFunc BreastCaPa ExpCa-Related CogImpai
Alexandre Chan
- OPEN TO ACCRUAL
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Ramy Hanna
- OPEN TO ACCRUAL
Personalized fluid administration using an assisted fluid management system
Sean Coeckelenbergh
- OPEN TO ACCRUAL
RadThe forHighriskAsymptomaticBoneMets PragmaticMulticentRandPhIIIClinicalTrial(PREEMPT)
Jeremy Harris
- OPEN TO ACCRUAL
Ph I CB-010 CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Ptsw/ R/R Non-Hodgkin Lymphoma
Susan O'Brien
- OPEN TO ACCRUAL
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
Behram Parvez Mody
- OPEN TO ACCRUAL
PhI/II Study ofREGN5668 Administered inCombw/Cemiplimab orREGN4018
Jill Tseng
- OPEN TO ACCRUAL
NKX019 in Subjects with Myasthenia Gravis
Ali Habib
- OPEN TO ACCRUAL
A Phase 1 Study of NKX019 in Subjects with Immune-Mediated Disease
Tahseen Mozaffar
- OPEN TO ACCRUAL
A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safety
Pengbo Jiang
- OPEN TO ACCRUAL
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topic
Maria Buethe
- OPEN TO ACCRUAL
SIENNA
Baruch Kuppermann
- OPEN TO ACCRUAL
GenePHIT: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects with Non-Ischemic NYHA Cl
Felice Lin
- OPEN TO ACCRUAL
A study to evaluate the efficacy and safety of frexalimab, SAR442970, or rilzabrutinib in participa
Ramy Hanna
- OPEN TO ACCRUAL
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Sanaz Attaripour Isfahani
- OPEN TO ACCRUAL
Lung Cancer Screening of Family Members of Patients with Mutation-Driven Lung Cancer
Hari Keshava
- OPEN TO ACCRUAL